NCT03787602 2023-03-02Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell CarcinomaKartos Therapeutics, Inc.Phase 1/2 Unknown115 enrolled
NCT03750071 2022-10-20VXM01 Plus Avelumab Combination Study in Progressive GlioblastomaVaximm GmbHPhase 1/2 Unknown30 enrolled